title: Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine.
abstract: Since the discovery of induced pluripotent stem cells (iPSCs) generation, much progress has been made in the fields of medical and pharmaceutical research, such as cell transplantation therapy. We have generated retinal cells and tissues, including retinal pigment epithelia (RPE), from human iPSCs. The ability to produce iPSCs from patients allows for autologous transplantation without causing immune rejection. The autologous transplantation of iPSC-derived retinal pigment epithelial sheets to a patient with age-related macular degeneration was carried out in Japan in 2014 as a first-in-human clinical study. Biotechnology has enabled the development of a wide range of drugs, including cell-based drugs. We are currently developing iPSC-derived RPE sheets as next-generation cell-based drugs aimed at allogeneic transplantation utilizing iPSC banks of homozygotes of human leukocyte antigen at 3 loci. Regulatory science concerning cellular and tissue-based products is a vital matter associated with the realization of regenerative medicine. Here we review the most recent progress in retinal regeneration and drug development, as well as its future prospects.
authors.affiliation: Laboratory of Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya University.
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Osakada
mesh_terms: D064591:Allografts; D064592:Autografts; D001709:Biotechnology / Q000379:methods / Q000639:trends; D064987:Cell- and Tissue-Based Therapy / Q000379:methods* / Q000639:trends*; D055808:Drug Discovery; D006680:HLA Antigens; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000637:transplantation*; D008268:Macular Degeneration / Q000628:therapy; D012038:Regeneration; D044968:Regenerative Medicine / Q000379:methods* / Q000639:trends*; D012160:Retina / Q000166:cytology* / Q000502:physiology*; D055213:Retinal Pigment Epithelium / Q000166:cytology
chemical_list: D006680:HLA Antigens